凝血酶敏感蛋白-1是cereblon的内源性底物,介导免疫调节药物诱导的血栓栓塞
研究探讨免疫调节药物(IMiDs)诱导血栓栓塞的分子机制,采用液相色谱-质谱法在人巨核细胞中鉴定cereblon底物,发现凝血酶敏感蛋白-1(THBS-1)为内源性底物;IMiDs抑制其蛋白酶体降解导致异常蓄积,并在接受IMiDs治疗的多发性骨髓瘤患者外周血单个核细胞中观察到THBS-1显著增加及血浆中更大的血管性血友病因子多聚体。
要点
- THBS-1是人巨核细胞中cereblon的内源性底物。
- IMiDs通过阻碍cereblon招募至THBS-1而抑制其蛋白酶体降解,导致THBS-1异常蓄积。
- 接受IMiDs治疗的骨髓瘤患者外周血单个核细胞中THBS-1显著增加,血浆中血管性血友病因子多聚体增大。
核心结论
- THBS-1是cereblon的内源性底物,IMiDs破坏该配对,THBS-1异常蓄积在IMiDs诱导的血栓栓塞发病机制中起重要作用。
研究设计与样本
- 研究采用液相色谱-质谱法在人巨核细胞中探究cereblon底物,并观察接受IMiDs治疗的多发性骨髓瘤患者外周血单个核细胞及血浆指标。
主要发现
- 在人巨核细胞中鉴定出THBS-1作为cereblon的内源性底物。
- IMiDs抑制THBS-1的蛋白酶体降解,导致THBS-1异常蓄积。
- 接受IMiDs治疗的骨髓瘤患者外周血单个核细胞中THBS-1显著增加,血浆中血管性血友病因子多聚体增大。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunomodulatory drugs (IMiDs) are key drugs for treating multiple myeloma and myelodysplastic syndrome with chromosome 5q deletion. IMiDs exert their pleiotropic effects through the interaction between cell-specific substrates and cereblon, a substrate receptor of the E3 ubiquitin ligase complex. Thus, identification of cell-specific substrates is important for understanding the effects of IMiDs. IMiDs increase the risk of thromboembolism, which sometimes results in fatal clinical outcomes. In this study, we sought to clarify the molecular mechanisms underlying IMiDs-induced thrombosis. We investigated cereblon substrates in human megakaryocytes using liquid chromatography-mass spectrometry and found that thrombospondin-1 (THBS-1), which is an inhibitor of a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13, functions as an endogenous substrate in human megakaryocytes. IMiDs inhibited the proteasomal degradation of THBS-1 by impairing the recruitment of cereblon to THBS-1, leading to aberrant accumulation of THBS-1. We observed a significant increase in THBS-1 in peripheral blood mononuclear cells as well as larger von Willebrand factor multimers in the plasma of patients with myeloma, who were treated with IMiDs. These results collectively suggest that THBS-1 represents an endogenous substrate of cereblon. This pairing is disrupted by IMiDs, and the aberrant accumulation of THBS-1 plays an important role in the pathogenesis of IMiDs-induced thromboembolism.
引用
- Hatakeyama K, Kikushige Y, Ishihara D, et al. Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism. Blood Adv. 2024. PMID: 38163319. doi:10.1182/bloodadvances.2023010080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。